| Stroke | ||||||||||
| Symptoms | ||||||||||
| F (face)- weakness or drooping, crooked smile, sudden loss of vision in one or both eyes | ||||||||||
| A (arms) - weak or drooping arm | ||||||||||
| S (speech) - slurred or inability to understand or be understood; inability to speak | ||||||||||
| T (time) - 4-5 minutes without oxygen causes brain cell death (IRREVERSIBLE) | ||||||||||
| NIH Stroke Scale | ||||||||||
| Risk Factors | ||||||||||
| Controllable/Treatable Risk Factors | ||||||||||
| 1. High Blood Pressure (140/90 or higher) - most important risk factor for stroke | ||||||||||
| 2. Tobacco use - major risk factor | ||||||||||
| 3. Diabetes mellitus | ||||||||||
| 4. Carotid or artery disease or peripheral artery disease | ||||||||||
| 5. Atrial fibrillation | ||||||||||
| 6. Other heart diseases - coronary heart disease, dilated cardiomyopathy, heart valve disease, congenital heart defects, etc. | ||||||||||
| 7. Transient ischemic attacks (TIA) - mini-strokes, which are warning signs of potential major stroke - patients with TIA's should be on antiplatelet regimen (i.e. aspirin, plavix, or aspirin + dipyridamole) | ||||||||||
| 8. Elevated red blood cell count - can be treated with blood thinners or removing excess red blood cells | ||||||||||
| 9. Sickle cell disease | ||||||||||
| 10. Elevated Cholesterol | ||||||||||
| 11. Physical Inactivity or Obesity | ||||||||||
| 12. Excessive alcohol intake | ||||||||||
| 13. Certain illicit drugs (IV drug abuse, cocaine) | ||||||||||
| Uncontrollable Risk Factors | ||||||||||
| 1. Increasing age | ||||||||||
| 2. Sex (gender) - more common in men | ||||||||||
| 3. Family history | ||||||||||
| 4. Prior stroke or heart attack - increases risk | ||||||||||
| Acute Management of Ischemic Stroke | ||||||||||
| Before any treatment, hemorrhagic stroke must be ruled out by CT scan | ||||||||||
| Any thrombolytic treatment must be initiated within three (3) hours of onset of stroke symptoms (i.e. tPA) | ||||||||||
| Medications | ||||||||||
| 1. tPA - total dose (recommended): 0.9mg/kg (maximum dose should not exceed 90mg) infused over 60 minutes. Load with 0.09mg/kg (10% of the 0.9mg/kg dose) as an IV bolus over 1 minute, followed by 0.81mg/kg (90% of the 0.9mg/kg dose) as a continuous infusion over 60 minutes. Heparin should not be started for 24 hours or more after starting alteplase (tPA) for stroke | ||||||||||
| 2. Aspirin 300mg should be given as soon as possible after the onset of stroke symptoms (unless being treated with thrombolytic agents - then should be held for 24 hours after treatment with thrombolytic). Aspirin (50-300mg) should be continued indefinitely until an alternative antiplatelet therapy is initiated | ||||||||||
| Thus far, none of the medications aimed at salvaging ischemic brain (i.e. neuroprotectors and drugs to reduce cerebral edema) have been approved for routine use | ||||||||||
| Acute Management of Subarachnoid Hemorrhagic Stroke | ||||||||||
| CT scan should be undertaken immediately if the patient has impaired level of consciousness, otherwise CT scan should be undertaken within 12 hours | ||||||||||
| Once diagnosis confimred: | ||||||||||
| 1. Nimodipine 60mg every 4 hours should be initiated (unless contraindicated) | ||||||||||
| 2. Anti-fibrinolytic agents and steroids should not be given | ||||||||||
| 3. General supportive measures to ensure adequate hydration and oxygenation should be instituted (including pain management) | ||||||||||
| Secondary Prevention | ||||||||||
| should be initiated within 7 days of acute stroke or TIA | ||||||||||
| 1. Lifestyle modifications - smoking cessation, regular exercise, modifying diet, reduced salt intake, and avoiding excess alcohol | ||||||||||
| 2. Blood pressure control - if blood pressure elevated for over two weeks, should be treated to keep <140/85 in all non-diabetic patients and <130/80 in diabetic patients (first line therapy should be ACE-I or ARB +/- diuretic (usually thiazide diuretic)) | ||||||||||
| 3. Anti-thrombotic therapy - all post-stroke patients should be on antiplatelet therapy (i.e. aspirin 50-300mg daily, plavix, or combination of aspirin plus dipyridamole modified release (aggrenox)) | ||||||||||
| 4. Anti-lipid therapy - all post-stroke patient's should be initiated on Zocor 40mg daily, unless contraindicated | ||||||||||
| 5. Anticoagulation therapy should not be routinely initiated, unless atrial fibrillation present | ||||||||||
| Return to Main Index | ||||||||||